Your treatment is important, just like you. That's why Biogen has developed different treatment options. Find out more about our medications for relapsing MS.
Our goal is to make sure no one has to give up on treating their disease because of financial limitations. Learn more about our $0 Copay Program and other helpful resources.
The Above MSTM program from Biogen is here for you with tips, tools, and personalized assistance for your MS—and more.
At Biogen, MS is not just what we do. It’s what motivates us to work harder.
Our commitment to MS fuels our passion to provide even more treatment options to people living with MS around the world. For the past two decades,
we’ve worked hard to develop a range of therapies to treat this disease. In fact, year after year, we reinvest a significant amount of our earnings into
product research and development to find new and different ways of treating relapsing forms of MS.
MS is at the core of everything we do. In fact, we’ve built our company on the foundation of dedication to people living with relapsing MS and research in treating this disease. And Biogen is the only company that offers four treatments for relapsing forms of MS.
Aside from all the medications we offer for relapsing forms of MS, Biogen has thousands of amazing employees. Many of us have a personal connection to MS. We may be living with this disease or know or love someone who has MS.
Senior Quality Associate
“I have a deep personal connection to MS. My wife, Germaine, was diagnosed in 2001 with the disease, just a year into our marriage. MS has always been a part of our lives.
For me, working at Biogen is very fulfilling. I feel like I’m doing something that matters for someone I love. The mission of our company is truly about people living with MS. It’s not just something we say. Biogen walks the walk. We are a company that looks beyond the condition, sees the whole perspective, and listens to the people who live with the disease.”
The process of developing a new treatment is a marathon not a sprint. There are
three key steps before a new treatment becomes available:
During this phase, researchers learn how the disease impacts the body and search for ways to fight the problem.
Before a new drug can be approved, it goes through extensive clinical trials to determine if it’s safe and effective. There are 3 distinct phases. At each successive phase, the drug is tested with larger groups of people.
Once a treatment is approved by the U.S. Food & Drug Administration (FDA), teams work to get it into patients’ hands by preparing the medicine for distribution. There is also ongoing monitoring for safety and unexpected side effects.